Letter – Location of Certain Hwang-Patent Info on Ecotropic Murine Leukemia Virus (EMLV)

Dear Mr. Tibbs: July 18th, 2010

The pre-formulations used for the development of HepC Herba™ had been tested against a murine retrovirus and were found to be active against Ecotropic Murine Leukemia Virus (EMLV) in vitro before they were tested active against HIV-1 exo vivo.

Please see the U.S. Patent 5,989,556, Example 4, Table 2 on page 23.

HepC Herba™ has also been found to help those who have chronic fatigue from chronic hepatitis C and mononucleosis from Epstein-Barr virus infection. Those who took HepC Herba™ generally have more energy after two weeks of taking the formulation three times a day orally like drinking a coffee.


Shie-Ming Hwang, Ph.D.

Leave a Reply

Your email address will not be published. Required fields are marked *